Dynavax Technologies | DVAX - PE Price to Earnings


Dynavax Technologies reported 13.52 in PE Price to Earnings for its fiscal quarter ending in September of 2025.



Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Adma Biologics 29.73 12.48 Dec/2025
Amgen 25.31 15.82 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
Glaxosmithkline 11.66 0.28 Dec/2025
Merck 13.92 5.08 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025